Clinical Trials
3 trialsNCT02756247 2022-10-10
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01719250 2018-10-09
Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01693614 2018-09-28
Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
Novartis
Phase 2 Completed